Application

15702281 · CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1-YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE AS OREXIN RECEPTOR ANTAGONIST

Filed 2017-09-12 · Granted · Patent 10023560 (2018-07-17) The official file ↗The patent and its PDF ↗ · Art unit 1626 · Examiner Golam M Shameem Easy · CPC C07D 403/14 · IDORSIA PHARMACEUTICALS LTD · HOXIE & ASSOCIATES LLC